Pursglove Geordan Garrett — SEC Form 4 filings

SEC reporting owner CIK 2073519. 4 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-07-09 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)CEO and Chairman of the Board, Director34
GridAI Technologies Corp. (GRDX)Director11

Form 4 filings — Pursglove Geordan Garrett

FiledFormIssuerReported transactionsSource
2026-07-024LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)Grant/award (A): 350,000 @ $0EDGAR
2026-04-174LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)Grant/award (A): 350,000 · Disposition to issuer (D): 350,000 (derivative)EDGAR
2026-01-054GridAI Technologies Corp. (GRDX)Grant/award (A): 40,000 @ $0EDGAR
2025-07-094LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)Grant/award (A): 350,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2073519 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →